Merit E Cudkowicz
MD, MSc
Dr. Merit E Cudkowicz
Innovator
Massachusetts General Hospital
| Organization | Role | Purpose | Compensation |
| AC Immune SA | Consultant | Consulting | Consulting Fees |
| Aclipse | Consultant | Consulting | Consulting Fees |
| Akava Therapeutics, Inc. | Consultant | Consulting | Equity |
| Arrowhead | Consultant | Consulting | Consulting Fees |
| BrainTrust | SAB | Equity | |
| Coya | Consultant | Consulting | Consulting Fees/Equity |
| Cytokinetics | Consultant | Consulting | Consulting Fees |
| Immunity Pharma Ltd | Consultant | Consulting Services | Consulting Fees |
| InFlectis | Consultant | Consulting | Consulting Fees |
| Locust Walk | Consultant | Consulting | Consulting Fees |
| Merck Sharp & Dohme | Consultant | Consulting | Consulting Fees |
| NeuroSense | Consultant | Consulting | Consulting Fees |
| Novartis | Consultant | Consulting | Consulting Fees |
| Novartis | Consultant | Consulting | Consulting Fees |
| Ono | Consultant | Consulting | Consulting Fees |
| Otsuka Pharmaceutical Development & Commercialization | Consultant | Consulting | Consulting Fees |
| Pasithea | Consultant | Consulting | Consulting Fees |
| Pontifax | Consultant | Consulting | Consulting Fees |
| Praxis | Consultant | BOD | Consulting Fees/Equity |
| QurAlis | Consultant | Consulting | Consulting Fees |
| Regeneron Pharmaceuticals | Consultant | Consulting | Consulting Fees |
| Takeda Development Center Americas | Consultant | Consulting | Consulting Fees |
| Transposon | Consultant | Consulting | Consulting Fees |
| VectorY | Consultant | Consulting | Consulting Fees |
Patent (09/23/2014)
US Patent 8841077 issued: "Biomarkers for amyotrophic lateral sclerosis and methods using the same"
Dr. Merit Cudkowicz is the Julianne Dorn Professor of Neurology at Massachusetts General Hospital and at Harvard Medical School. Dr. Cudkowicz completed medical training at the Health Science and Technology program of Harvard Medical School, and she was a resident in Neurology at Mass General. She obtained a Master's degree in Clinical Epidemiology from the Harvard School of Public Health. Dr. Cudkowicz's research and clinical activities are dedicated to the study and treatment of patients with neurodegenerative disorders, in particular amyotrophic lateral sclerosis (ALS). Dr. Cudkowicz directs the Mass General ALS clinic and the Neurological Clinical Research Institute (NCRI) (formerly the NCTU). She is one of the founders and co-directors of the Northeast ALS Consortium (NEALS), a group of 92 clinical sites in the United States and Canada dedicated to performing collaborative academic led clinical trials in ALS. In conjunction with the NEALS consortium, she planned and completed seven multi-center clinical trials in ALS and is currently leading three new trials in ALS. Dr. Cudkowicz received the American Academy of Neurology 2009 Sheila Essay ALS award. She is actively mentoring young neurologists in clinical investigation. Dr. Cudkowicz is on the Research Council of the American Acadenmy of Neurology and the medical advisory board for the Muscular Dystrophy Association.